Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Huang, Fei ^a   Yang, Zhi ^a   Xu, Baihui ^a   Bi, Yufang ^a   Xu, Min ^a   Xu, Yu ^a   Lu, Jieli ^a   Liu, Yu ^a   Dai, Meng ^a   Zhou, Wenzhong ^a   Wang, Weiqing ^a   Chen, Yuhong ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; PREDICTION; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 84872830970     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054628     Document Type: Article

References (31)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
2. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24: 1601-1610.
3. Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, et al. (2000) Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 101: 477-484.
4. Simon A, Chironi G, Levenson J, (2007) Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J 24: 2967-2971.
5. Contois JH, McConnell JP, Sethi AA, Csako G, Devaraj S, et al. (2009) Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices. Clin Chem 55: 407-419.
6. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M, (2007) Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115: 459-467.
7. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, et al. (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146: 483-494.
8. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340: 14-22.
9. Dahlén EM, Länne T, Engvall J, Lindström T, Grodzinsky E, et al. (2009) Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes. Diabet Med 26: 384-390.
10. Shaw JE, Zimmet PZ, McCarty D, de Courten M (2000) Type 2 diabetes worldwide according to the new classification and criteria. Diabetes Care (Suppl. 2): B5-B10.
11. Matthews RD, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
12. Huang Y, Bi Y, Wang W, Xu M, Xu Y, et al. (2011) Glycated hemoglobin A1c, fasting plasma glucose, and two-hour postchallenge plasma glucose levels in relation to carotid intima-media thickness in chinese with normal glucose tolerance. J Clin Endocrinol Metab 96: E1461-1465.
13. Olofsson SO, Wiklund O, Boren J, (2007) Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease. Vasc Health Risk Manag 3: 491-502.
14. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, et al. (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358: 2026-2033.
15. Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, et al. (1999) Thrombogenic factors and recurrent coronary events. Circulation 99: 2517-2522.
16. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, et al. (1996) Apolipoprotein A-1 and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation 94: 273-278.
17. Meisinger C, Loewel H, Mraz W, Koenig W, (2005) Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J 26: 271-278.
18. Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, et al. (2009) Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 30: 710-717.
19. Juonala M, Viikari JS, Kähönen M, Solakivi T, Helenius H, et al. (2008) Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol 52: 293-299.
20. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, et al. (2011) Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 365: 213-221.
21. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, et al. (2007) Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J 28: 398-406.
22. Williams K, Sniderman AD, Sattar N, D'Agostino R Jr, Wagenknecht LE, et al. (2003) Comparison of the association of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 108: 2312-2316.
23. Wallenfeldt K, Bokemark L, Wikstrand J, Hulthe J, Fagerberg B, (2004) Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35: 2248-2252.
24. Tabas I, Williams KJ, Borén J, (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116: 1832-1844.
25. Mora S, Szklo M, Otvos JD, Greenland P, Psaty BM, et al. (2007) LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192: 211-217.
26. St-Pierre AC, Bergeron J, Pirro M, Cantin B, Dagenais GR, et al. (2003) Effect of plasma C-reactive protein levels in modulating the risk of coronary heart disease associated with small, dense, low-density lipoproteins in men (The Quebec Cardiovascular Study). Am I Cardiol 91(5): 555-8.
27. van Deventer HE, Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, et al. (2011) Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population. Clin Chem 57(3): 490-501.
28. Hsia SH, Pan D, Berookim P, Lee ML, (2006) A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease. Am J Cardiol 98: 1047-1052.
29. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, et al. (2007) Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298: 776-785.
30. Genest J, Frohlich J, Fodor G, McPherson R, (2003) Recommendations for the management and treatment of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Can Med Assoc J 169: 921-924.
31. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, et al. (2008) Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 31: 811-822.